Skip to main content
  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

AACR logo

  • Register
  • Log in
  • My Cart
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
    • CME
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • CCR Focus Archive
    • Meeting Abstracts
    • Collections
      • COVID-19 & Cancer Resource Center
      • Breast Cancer
      • Clinical Trials
      • Immunotherapy: Facts and Hopes
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in
  • My Cart

Search

  • Advanced search
Clinical Cancer Research
Clinical Cancer Research
  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
    • CME
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • CCR Focus Archive
    • Meeting Abstracts
    • Collections
      • COVID-19 & Cancer Resource Center
      • Breast Cancer
      • Clinical Trials
      • Immunotherapy: Facts and Hopes
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

Cancer Therapy: Preclinical

Antibody and CD8+ T Cell Responses against HER2/neu Required for Tumor Eradication after DNA Immunization with a Flt-3 Ligand Fusion Vaccine

Francesca Orlandi, Franco M. Venanzi, Antonio Concetti, Hanako Yamauchi, Shakuntala Tiwari, Larry Norton, Jedd D. Wolchok, Alan N. Houghton and Polly D. Gregor
Francesca Orlandi
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Franco M. Venanzi
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Antonio Concetti
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hanako Yamauchi
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Shakuntala Tiwari
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Larry Norton
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jedd D. Wolchok
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alan N. Houghton
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Polly D. Gregor
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI: 10.1158/1078-0432.CCR-07-0258 Published October 2007
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Online Impact

Statistics from Altmetric.com

ARTICLE USAGE

ARTICLE USAGE: October 2007 to February 2021

AbstractFull-text HTMLPDF
Total211619561409

Cited By

Article Information

Volume 13, Issue 20, pp. 6195-6203

DOI 
https://doi.org/10.1158/1078-0432.CCR-07-0258
PubMed 
17947487

Published By 
American Association for Cancer Research
Print ISSN 
1078-0432
Online ISSN 
1557-3265
History 
  • Accepted July 9, 2007
  • Received January 31, 2007
  • Revision received July 2, 2007
  • Published first October 18, 2007.

Copyright & Usage 
American Association for Cancer Research

Author Information

  1. Francesca Orlandi1,
  2. Franco M. Venanzi2,
  3. Antonio Concetti2,
  4. Hanako Yamauchi1,
  5. Shakuntala Tiwari1,
  6. Larry Norton1,
  7. Jedd D. Wolchok1,
  8. Alan N. Houghton1 and
  9. Polly D. Gregor1
  1. Authors' Affiliations:1Swim Across America Laboratory. Memorial Sloan-Kettering Cancer Center, New York, New York; and 2Unit of Translational Medicine. University of Camerino, Camerino (MC), Italy
  1. Requests for reprints:
    Polly D. Gregor, Department of Medicine, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY 10021. Phone: 646-888-2545; Fax: 646-422-0453; E-mail: gregorp{at}mskcc.org.
View Full Text
PreviousNext
Back to top
Clinical Cancer Research: 13 (20)
October 2007
Volume 13, Issue 20
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover

Sign up for alerts

View this article with LENS

Open full page PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Clinical Cancer Research article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Antibody and CD8+ T Cell Responses against HER2/neu Required for Tumor Eradication after DNA Immunization with a Flt-3 Ligand Fusion Vaccine
(Your Name) has forwarded a page to you from Clinical Cancer Research
(Your Name) thought you would be interested in this article in Clinical Cancer Research.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Antibody and CD8+ T Cell Responses against HER2/neu Required for Tumor Eradication after DNA Immunization with a Flt-3 Ligand Fusion Vaccine
Francesca Orlandi, Franco M. Venanzi, Antonio Concetti, Hanako Yamauchi, Shakuntala Tiwari, Larry Norton, Jedd D. Wolchok, Alan N. Houghton and Polly D. Gregor
Clin Cancer Res October 15 2007 (13) (20) 6195-6203; DOI: 10.1158/1078-0432.CCR-07-0258

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Antibody and CD8+ T Cell Responses against HER2/neu Required for Tumor Eradication after DNA Immunization with a Flt-3 Ligand Fusion Vaccine
Francesca Orlandi, Franco M. Venanzi, Antonio Concetti, Hanako Yamauchi, Shakuntala Tiwari, Larry Norton, Jedd D. Wolchok, Alan N. Houghton and Polly D. Gregor
Clin Cancer Res October 15 2007 (13) (20) 6195-6203; DOI: 10.1158/1078-0432.CCR-07-0258
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results
    • Discussion
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF
Advertisement

Related Articles

Cited By...

More in this TOC Section

  • Survivin mAbs Inhibit Tumor Growth
  • B7-H3 Negatively Modulates Cancer Immunity
  • RB1 and TYMP as Biomarkers of Capecitabine Response in TNBC
Show more Cancer Therapy: Preclinical
  • Home
  • Alerts
  • Feedback
  • Privacy Policy
Facebook  Twitter  LinkedIn  YouTube  RSS

Articles

  • Online First
  • Current Issue
  • Past Issues
  • CCR Focus Archive
  • Meeting Abstracts

Info for

  • Authors
  • Subscribers
  • Advertisers
  • Librarians

About Clinical Cancer Research

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2021 by the American Association for Cancer Research.

Clinical Cancer Research
eISSN: 1557-3265
ISSN: 1078-0432

Advertisement